Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure

This publication has 10 references indexed in Scilit:

• Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
  Circulation, 1995
• Role of endothelin in the exercise intolerance of chronic heart failure
  The American Journal of Cardiology, 1995
• Increased Plasma Concentrations of Endothelin in Congestive Heart Failure in Humans
  Mayo Clinic Proceedings, 1992
• Plasma endothelin in chronic heart failure.
  Circulation, 1992
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.
  Hypertension, 1992
• Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.
  Circulation, 1992
• A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects
  Clinical Science, 1990
• Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
  Circulation, 1986
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984
• Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography
  Analytical Chemistry, 1981